It has been reported that PPAR-γ deletion induces an increment of the inflammatory process in the DSS model of intestinal inflammation, whereas its activation represses the nuclear localization of NF-κB [81,83], showing NF-κB-dependent response of PPAR-γ as a target for the action of intestinal anti-inflammatory compounds. Here, NFKB1 is linked to inflammation.